reverse merger

For biotech dealmakers, it’s everything, everywhere all at once
Fierce Biotech
Wed, 01/17/24 - 09:40 am
M&A
IPOs
reverse merger
venture capital
Pencils down for Graphite, as gene editing biotech merges into vision-loss-focused Lenz
Fierce Biotech
Wed, 11/15/23 - 11:55 am
Lenz Therapeutics
Graphite Bio
gene editing
reverse merger
vision loss
M&A
Humanigen mulls bankruptcy after reverse merger falls through
Fierce Biotech
Tue, 07/25/23 - 10:12 am
Humanigen
reverse merger
M&A
bankruptcy
A cancer biotech’s collapse gives Neurogene a path to Wall Street
BioPharma Dive
Tue, 07/18/23 - 10:01 pm
Neurogene
gene therapy
reverse merger
Neoleukin
Korro Bio merges with off-pitch Frequency, hits Wall Street with $117M
Fierce Biotech
Fri, 07/14/23 - 11:54 am
M&A
reverse merger
Korro Bio
Frequency Therapeutics
Immunome, Morphimmune reverse merge, with ex-Seagen CEO Clay Siegall to lead a year after domestic abuse arrest
Fierce Biotech
Fri, 06/30/23 - 11:42 am
Immunome
Morphimmune
Clay Siegall
M&A
reverse merger
Conditions are ripe for reverse mergers
EP Vantage
Fri, 02/24/23 - 08:48 am
M&A
reverse merger
Redx
Jounce Therapeutics
Pherecydes
Erytech
Flame Biosciences
Leap Therapeutics
Elicio Therapeutics
Angion
Bone Fixes Fracture with "Synergistic" Reverse Merger, Becomes BioSenic
BioSpace
Fri, 10/28/22 - 10:36 am
Bone Therapeutics
cell therapy
M&A
reverse merger
Medsenic
BioSenic
As Forte fails, who might yet improve the image of reverse mergers?
EP Vantage
Wed, 09/8/21 - 11:04 am
reverse merger
M&A
Forte Biosciences
Tocagen
Nautilus set to go public in reverse merger with Perceptive SPAC, aims to test proteomics platform with big-name backers
Endpoints
Tue, 02/9/21 - 11:21 am
Nautilus Biotechnology
NASDAQ
SPAC
IPOs
reverse merger
M&A
Arya Sciences
Obliterated by Alzheimer's failure, Neurotrope relinquishes its Nasdaq spot in reverse merger
Endpoints
Mon, 05/18/20 - 10:47 am
M&A
reverse merger
Neurotrope BioSciences
Metuchen
Petros
Reverse mergers give and they take away
EP Vantage
Wed, 01/29/20 - 10:25 am
Conatus
NewLink
reverse merger
M&A
Histogen
Lumos Pharma
In the latest reverse merger, Vienna's Arsanis serves as vehicle for X4 Pharma's Nasdaq listing
Endpoints
Tue, 11/27/18 - 11:29 pm
biotech
reverse merger
M&A
Arsanis
X4 Pharma
Acer aims for public listing through reverse merger
BioPharma Dive
Sun, 07/9/17 - 11:35 am
Acer
reverse merger
M&A
Opexa Therapeutics
Former Dendreon CEO debuts new public company in reverse merger
BioPharma Dive
Wed, 04/19/17 - 04:19 pm
Dendreon
reverse merger
Mitchell Gold
Alpine Immune Sciences
Nivalis